Photo Acknowledgement: John Welch

Winners of Past Research Grants

The below lists the last 10 years of research grants awarded.  For information for grants prior to this, please contact the Secretariat.

Year

awarded

Grant Author Location at time of grant Title/Link to publication
2023
$60,000
Pfizer
Dr Claudia Swan Auckland Investigating the relationship between hair cortisol concentration and weight gain and body composition in infancy and early childhood
2023
$20,000
Sandoz
Dr Jessica Sandy Sydney Dental manifestation in paediatric X-linked hypophosphataemia’
2023
$35,000
Novo Nordisk
Dr Chris Lawrence Newcastle Screening for disordered eating behaviours in type 1 diabetes: Can technology enable early detection?
2023
$25,000
ANZSPED
Sabrina Binkowski Perth Clinical outcomes in Culturally and Linguistically diverse Youth with Type 1 diabetes in Western Australia
2023
$20,000
APR
Dr Sarah Black Perth Growth and RASopathies: Review of growth hormone effects in an Australian context, an observational study utilizing the ANZSPED patient registry (APR)
2022 $60,000
Pfizer
Dr Sarah Pinto Melbourne The Role of Macrophages in Development and Progression of Type 1 Diabetes Mellitus
2022 $20,000
Pfizer
Dr Gabby Atlas Melbourne Using Whole Genome Sequencing to improve diagnoses for individuals with Differences of Sex Development
2022 $20,000
Pfizer
Dr Lara Graves Sydney Single cell transcriptomic analysis for identification of recombinant adeno-associated virus serotypes for efficient gene delivery to the adrenal cortex
2022 $25,000
NovoNordisk
Dr Kruthika Narayan Sydney Role of continuous glucose monitoring in presymptomatic type 1 diabetes detected by general population screening,
2022 $15,000
Sandoz
Dr David Cullingford Perth Septo-optic Dysplasia: Aetiology, Burden of Disease and Pathophysiology of Hypopituitarism (SODA BUD)
2022 $25,000 APEG Yoon Hi Cho Sydney Molecular testing in risk stratification of paediatric thyroid nodules of indeterminate pathology
2022 $20,000 APR Paul Benetiz-Aguirre Sydney Investigating long term outcomes of childhood thyroid cancer
2021
$60,000 Pfizer Dr Karissa Ludwig Sydney The diagnosis and characterization of primary bone disorders using urinary stem cells
2021
$25,000 NovoNordisk Dr Tenele Smith Newcastle A cross-over, randomised controlled trial examining the efficacy of OptimAPP, a novel smartphone insulin dose calculator for carbohydrate, fat and protein in managing postprandial glycaemia following ‘problematic foods’ in children and young people with type 1 diabetes using insulin pump therapy
2021
$25,000 APEG Dr Erin Sharwood Queensland Circadian activity rhythm and hormone function, sleep, fatigue and body composition in early survivors of childhood brain tumours
2021
$20,000 Pfizer Dr Martin de Bock Christchurch The effect of non-funded continuous glucose monitoring on health equity in paediatric diabetes in Aotearoa, New Zealand
2021
$15,000 Sandoz Dr Jessica Sandy Sydney ‘Multicentre 24-month Outcome Data on real world use of Burosamab: biochemical, functional, radiological outcomes and acceptability study
2020
$60,000 Pfizer Dr Dana Signal Auckland Specialized dietary intervention in children with type 1 diabetes
2020
$25,000 NovoNordisk Dr Kerry Buchanan Brisbane Markers of endoplasmic reticulum stress in children with recent-onset type 1 diabetes
2020
$15,000 Sandoz Dr Verity Pacey Sydney Development of Allied Health Management Guidelines for Children and Adolescents with Osteogenesis Imperfecta
2020
$15,000 APEG Dr Lucinda Lee Sydney Generating novel AAV vectors for preclinical modelling of gene therapy treatment for diabetes and other endocrine disorders
2020
$10,000 Sanofi Dr Mercedes Burnside Christchurch Addressing the minority Diabetes Divide: A CREATE (Community derived AutomaTEd insulin delivery) Trial Sub-study
2019
$60,000 Pfizer Lara Graves Sydney Genome editing as a therapeutic approach to Congenital Adrenal Hyperplasia
2019
$25,000 NovoNordisk Gabby Atlas Melbourne Disorders of Sex Development:new approaches to improving diagnosis.
2019
$15,000
Sandoz
Andrew Biggin Sydney Understanding the genetic and cellular mechanisms of reduced bone health caused by obesity
2019
$15,000 APEG Mark de Hora Auckland Bloodspot Steroid Profiling by Liquid Chromatography Mass Spectrometry-Improving clinical outcomes in congenital adrenal hyperplasia.
2019 $10,000 Sanofi Rowen Seckold Newcastle Optimising postprandial Glycaemia in children and young people with Type 1 Diabetes using Hybrid Closed Loop insulin delivery: Current challenges and practical clinical solutions.
2018 $25,000 NovoNordisk Andrew Biggin Sydney Improving height and bone strength in osteogenesis imperfecta using combination growth hormone and bisphosphonate therapy
2018 $15,000 Sandoz Yassmin Musthaffa Brisbane Insights into growth outcomes in paediatric Turner Syndrome from high-throughput transcriptome and epigenome analyses
2018 $15,000 APEG Aveni Haynes Perth Using continuous glucose monitoring (CGM) to characterise early dysglycaemia in young children at risk of Type 1 diabetes
2018 $10,000 Sanofi Sara Boucher Dunedin ‘Flash’ adhesive study: A randomised trial comparing tape and dressings to prolong sensor life in youth using the FreeStyle Libre flash glucose monitoring system
2017 $25,000 Novo Nordisk Prudence Lopez Newcastle Defining the optimal insulin management for high fat and protein meals in children and young people with Type 1 Diabetes (T1D) using multiple daily insulin injection (MDI) therapy
2017 $15,000 Sandoz Matthew Sabin Melbourne CardioMetabolicRisk in Youth Obesity: investigating growth trajectories for later disease – The COBRA-CMR study
2017 $10,000 Sanofi Benjamin Wheeler Dunedin Sleep disturbances in parents of children diagnosed with type 1 diabetes
2017 $10,000 APEG Ashleigh Lin Perth Characterising fluctuations in stress, anxiety and blood glucose levels in adolescents with type 1 diabetes
2016 $25,000 Novo Nordisk Carmel Smart Newcastle Establishment of an insulin dosing schedule for high fat, high protein meals in individuals with type 1 diabetes using insulin pump therapy
2016 $10,000 APEG Karen Rothacker Perth The effect of hyperglycaemia in standard and low insulin states on exercise performance compared to exercise performance in euglycaemia
 2016 $15,000 Sandoz Rebecca Pelekanos Brisbane Developing a multifaceted molecular pipeline to predict good and poor responders to recombinant growth hormone therapy
2015 $25,000 NovoNordisk Paul Hofman Auckland Does subclinical congenital hypothyroidism cause long term cognitive impairment?
2015 $15,000 Sandoz Ian Hughes Brisbane Relationships between IGF-1 Values and Growth Hormone Dose and Response to Treatment in Children Treated Under the Australian Growth Hormone Program: An OZGROW Analysis?
2014 $25,000 NovoNordisk Tim Jones Perth Neurocognitive development of children and adolescents with type 1 diabetes mellitus
2014 $10,000 Merck Serono Denise Steers Wellington Gender bender, mender or defender? Disorder of sex development –Navigating clinical decision making in New Zealand
2014 $10,000 SciGen Stephanie Johnson Brisbane To determine the prevalence of MODY in a paediatric diabetes population using Next Generation Sequencing
2014 $15,000
Eli Lilly
Tony Huynh Brisbane The establishment of HPLC-MS/MS-based dried blood spot 17-OHP target ranges for glucocorticoid dose adjustment in children with Congenital Adrenal Hyperplasia
2013 $25,000 Novo Nordisk Carmel Smart Newcastle A comparison of three insulin dosage algorithms for meals of variable macronutrient composition on postpranial glucose levels in children with type 1 diabetes
2013 $10,000 SciGen Grant Penny Jeffrey Brisbane Appetite hormone regulation in Prader-Will Syndrome